Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 1995
Business Overview: The Company manufactures and distributes natural health and nutritional products through a direct sales network of independent Managers and Distributors. Operations are conducted domestically and internationally, with significant recent expansion in Japan and Brazil.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1995 |
Six Months Ended June 30, 1994 |
Three Months Ended June 30, 1995 |
Three Months Ended June 30, 1994 |
|---|---|---|---|---|
| Sales Revenue | $97,787,079 | $75,649,184 | $50,725,319 | $38,312,202 |
| Net Income | $4,986,115 | $3,937,993 | $2,972,228 | $2,236,875 |
| Net Income Per Share | $0.40 | $0.31 | $0.24 | $0.18 |
| Operating Income | $7,638,709 | $6,672,560 | $4,651,659 | $3,605,359 |
| Net Cash from Operations | $5,599,392 | $6,035,751 | N/A | N/A |
| Cash and Equivalents (End of Period) | $12,906,462 | $10,703,819 | $12,906,462 | N/A |
| Short-Term Debt | $2,166,497 | $1,533,042 | $2,166,497 | N/A |
| Inventory | $18,749,819 | $17,277,762 | $18,749,819 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Sales revenue increased 29% for the six months and 32% for the three months ended June 30, 1995, compared to the prior year. This growth was driven by an expanded independent sales force (Managers increased to 10,396; Distributors to 280,830) and international expansion.
- Profitability: Net income rose 26.6% for the six-month period and 32.9% for the three-month period. Operating margins remained stable, though Selling, General, and Administrative (SG&A) expenses increased as a percentage of sales due to startup costs in new international markets.
- International Performance: International sales grew 45% to $32.1 million for the six months, offsetting a 47% sales decline in Mexico caused by the Peso devaluation. Japan and Brazil contributed significantly to growth despite initial operating losses.
- Liquidity: Cash and cash equivalents increased by $1.7 million to $12.9 million, supported by strong operating cash flows despite capital expenditures of $1.7 million and treasury stock purchases of $1.3 million.
Guidance, Outlook, and Risks
- Outlook: Management expects volume incentives and cost of goods sold to decrease slightly as a percentage of sales for the remainder of 1995 as newer operations (Japan, Brazil) mature. SG&A is also expected to decrease as a percentage of sales as revenue in these new markets increases.
- Capital Allocation: The Company has a stock buyback program with approximately 81,000 shares remaining to be purchased. Management intends to fund future working capital requirements internally but may seek long-term financing for potential domestic manufacturing and facility expansions.
- Risks and Contingencies:
- Foreign Exchange: The Company faces currency risk, evidenced by a 47% sales drop in Mexico due to economic turmoil and a net foreign exchange loss of $212,863 for the six months.
- Related Party Transactions: The Company advanced $120,000 to an officer (repaid) and $250,000 to a key employee (collateralized, 9% interest) during the period.
- Market Conditions: Future cash levels may be reduced if the Company proceeds with significant capital projects for facility expansion.
Investor Verification Checklist
- International Exposure: Verify the sustainability of sales growth in Japan and Brazil versus the volatility in Mexico.
- SG&A Efficiency: Monitor if SG&A expenses decrease as a percentage of sales in the second half of 1995 as projected by management.
- Related Party Loans: Confirm the repayment status of the $250,000 loan to the key employee and any future related-party advances.
- Inventory Turnover: Assess if inventory growth (9%) remains aligned with sales growth (29%) to prevent obsolescence or cash flow strain.
- Dividend Continuity: Note the declaration of the 28th consecutive quarterly cash dividend ($0.05/share), indicating management confidence in cash flow.